Methyl 2-(3-Oxo-1,2,3,4-Tetrahydroquinoxalin-2-Yl)Acetate 50702 aiding in environmental monitoring and

aiding in environmental monitoring and quality control

providing insights into their therapeutic potential and safety profiles

contributing to advancements in biochemistry and molecular biology

Radiopharmaceuticals: Strontium iodide is employed in the development of radiopharmaceuticals for targeted cancer therapies

Methyl 2-(3-Oxo-1,2,3,4-Tetrahydroquinoxalin-2-Yl)Acetate 50702 aiding in environmental monitoring andMethyl 2 (3 Oxo 1,2,3,4 Tetrahydroquinoxalin 2 Yl)Acetate is widely utilized in research focused on: Pharmaceutical Development: This compound serves as a key intermediate in the synthesis of various pharmaceutical agents, particularly those targeting neurological disorders, enhancing drug efficacy and specificity. Biochemical Research: It is employed in studies investigating enzyme activity and metabolic pathways, providing insights into cellular